Realheart is a public company listed on Nasdaq First North Growth Market since December 17 2021, under the name (HEART).
The Innovator of the Year is appointed by Almi Mälardalen. The prize is awarded to an innovative person, team or company that has developed an exemplary service or product that is completely new to the market in some respect.
The Swedish innovation tradition has provided the world with medical technological inventions such as the heart and lung machine, the pacemaker and the dialysis machine. The next great innovation is Realheart’s artificial heart, Realheart TAH, a Swedish invention that not only saves lives but also creates a better quality of a prolonged life.